Cargando…

PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL

Detalles Bibliográficos
Autores principales: Shen, Yandong, Freeman, Jane, Kerridge, Ian, Naidu, Kartik, Holland, Juliette, Mulligan, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430022/
http://dx.doi.org/10.1097/01.HS9.0000974556.83221.a1
_version_ 1785090854160957440
author Shen, Yandong
Freeman, Jane
Kerridge, Ian
Naidu, Kartik
Holland, Juliette
Mulligan, Stephen
author_facet Shen, Yandong
Freeman, Jane
Kerridge, Ian
Naidu, Kartik
Holland, Juliette
Mulligan, Stephen
author_sort Shen, Yandong
collection PubMed
description
format Online
Article
Text
id pubmed-10430022
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104300222023-08-17 PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL Shen, Yandong Freeman, Jane Kerridge, Ian Naidu, Kartik Holland, Juliette Mulligan, Stephen Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430022/ http://dx.doi.org/10.1097/01.HS9.0000974556.83221.a1 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Shen, Yandong
Freeman, Jane
Kerridge, Ian
Naidu, Kartik
Holland, Juliette
Mulligan, Stephen
PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL
title PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL
title_full PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL
title_fullStr PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL
title_full_unstemmed PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL
title_short PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL
title_sort pb1934: measured optimum anti-spike level vaccination strategy and anti-viral access result in low covid hospitalisation and mortality in cll and mbl
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430022/
http://dx.doi.org/10.1097/01.HS9.0000974556.83221.a1
work_keys_str_mv AT shenyandong pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl
AT freemanjane pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl
AT kerridgeian pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl
AT naidukartik pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl
AT hollandjuliette pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl
AT mulliganstephen pb1934measuredoptimumantispikelevelvaccinationstrategyandantiviralaccessresultinlowcovidhospitalisationandmortalityincllandmbl